-
The federal government announced several big changes to its vaccine plans, upending earlier guidance about whom to prioritize for the next phase.
-
The new deal effectively doubles the federal government's order from the company. Pfizer says the U.S. government has agreed to pay $1.95 billion for the additional doses.
-
A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.
-
A three-judge panel found the Trump administration failed to analyze whether such requirements "would promote the primary objective of Medicaid — to furnish medical assistance," as required by law.
-
The declaration allows the government to take special measures to contain the spread of the virus. Those include new restrictions on travel from China.
-
The federal government is taking action to pull many flavored products popular with kids off the market. Public health advocates say the move doesn't go far enough.
-
The administration called on other nations to oppose efforts to promote access to abortion. Dozens of other countries signed a competing statement supporting sexual and reproductive health care.
-
After criticism that the administration's blueprint for drug prices was vague, the secretary of health and human services zeroed in on actions that he said need only his signature.
-
If the former drug company executive is confirmed by the Senate, he would replace Dr. Tom Price, who resigned in September after a scandal involving government travel on private aircraft.